BGA
PGNX

Belmont Global Advisors’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Belmont Global Advisors’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-75,000
Closed -$307K – 151
2014
Q1 		$307K Buy
+75,000
New +$307K 0.26% 86